PRESS-RELEASE ·Filed May 19, 2026
Press release · Announcement
Actionable Insight ▼ Bearish
Monitor post-split price action and Nasdaq compliance status. Reverse splits in micro-caps often precede further declines due to negative signaling and reduced liquidity.
Final — all horizons settled through T+60d ⚠ clustered
CMND ▼ -21.61% at T+60d
SHORT call ✓ call won +21.61% · α vs SPY +27.90% · entry $2.36 → $1.85
T+1d
+6.78%
call -6.78% · α -5.74%
$2.52
settled 5mo ago
T+5d
+9.28%
call -9.28% · α -7.04%
$2.58
settled 5mo ago
T+20d
+33.05%
call -33.05% · α -32.07%
$3.14
settled 4mo ago
T+60d
-21.61%
call +21.61% · α +27.90%
$1.85
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Clearmind Medicine announces a 1-for-10 reverse stock split effective May 21, 2026, to regain compliance with Nasdaq's minimum bid price rule. The move highlights ongoing listing risk for the micro-cap biotech.
Key Facts
- Reverse stock split ratio of 1-for-10, effective May 21, 2026.
- Reduces outstanding shares from ~10.19M to ~1.02M (subject to fractional rounding).
- Approved by board on March 18, 2026; authorized share capital unchanged.
- Split intended to regain compliance with Nasdaq Minimum Bid Price Rule.
Financial Impact
No direct financial impact; reduces share count from ~10.19M to ~1.02M.
share countstock price
Risk Factors
- Possible failure to regain or sustain Nasdaq compliance
- Post-split selling pressure from retail investors
- Dilution risk if further capital raises are needed
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3297244 |
65 reports for CMND
50% Hit rate @ T+60 Went positive at some point 15 of 20 best @ T+60▲ +75.73%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $5.92 | awaiting T+60 | — | $5.95 (+0.47%) |
Oct 27, 2026 today | Press Release | $6.50 | awaiting T+60 | — | $5.95 (−8.50%) |
Oct 16, 2026 10d ago | 6-K | $6.00 | awaiting T+60 | — | $5.95 (+0.87%) |
Oct 13, 2026 14d ago | 6-K | $6.23 | awaiting T+60 | — | $5.95 (−4.53%) |
Oct 8, 2026 19d ago | 6-K | $6.60 | awaiting T+60 | — | $5.95 (−9.88%) |
Oct 7, 2026 20d ago | 6-K | $6.60 | awaiting T+60 | — | $5.95 (−9.88%) |
Sep 23, 2026 4w ago | 6-K | $0.8500 | awaiting T+60 | — | $5.95 (+599.72%) |
Sep 23, 2026 4w ago | Press Release | $0.8500 | awaiting T+60 | — | $5.95 (+599.72%) |
Sep 17, 2026 5w ago | Press Release | $6.86 | awaiting T+60 | — | $5.95 (−13.35%) |
Sep 14, 2026 6w ago | 6-K | $0.9440 | awaiting T+60 | — | $5.95 (+530.04%) |
Showing 10 of 65
US Market Status
Market Open — Closes in 2h 34m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers